Strattera and Stroke - a phase IV clinical study of FDA data

Summary:

Stroke is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Lisinopril, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Stroke when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,324 Strattera users. Check the latest studies of Strattera.

What is Stroke?

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen) is found to be associated with 2,311 drugs and 3,034 conditions by eHealthMe. Check the latest studies of Stroke.

On Aug, 04, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 74 people (0.27%) have Stroke.

Among these 74 people:

How long have people been on Strattera when they have Stroke? *

What is the gender of people who have Stroke when taking Strattera? *

female: 43.06 %
male: 56.94 %

What is the age of people who have Stroke when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Stroke? *

High Blood Pressure: 11 people, 14.86%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 9 people, 12.16%
Memory Loss: 7 people, 9.46%
Headache (pain in head): 7 people, 9.46%
Hemiparesis (weakness on one side of the body): 6 people, 8.11%
Pain: 6 people, 8.11%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 8.11%
Hypoaesthesia (reduced sense of touch or sensation): 5 people, 6.76%
Stress And Anxiety: 5 people, 6.76%
Speech Disorder: 5 people, 6.76%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 5 people, 6.76%
Psychomotor Hyperactivity (feelings of extreme restlessness): 3 people, 4.05%
Diabetes: 3 people, 4.05%
Immunodeficiency Common Variable: 2 people, 2.70%
Birth Control: 2 people, 2.70%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 2 people, 2.70%
Indigestion: 2 people, 2.70%
Drowsiness: 2 people, 2.70%
High Blood Cholesterol: 1 person, 1.35%
Bipolar Disorder (mood disorder): 1 person, 1.35%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Stroke?

- Check whether Stroke is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,324 reports)

Stroke treatments and more:

Stroke (334,635 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stroke:

Stroke (2,311 drugs)

Browse all the conditions that are associated with Stroke:

Stroke (3,034 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.